Tag: Lung Cancer Surgery Market Analysis

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Lung Cancer Surgery Equipment Market From 2026 To 2030?

The market size for lung cancer surgery equipment has experienced strong expansion in recent years. It is anticipated to increase from $3.73 billion in 2025 to $3.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. The observed growth during the historical period is attributable to the limited availability of advanced thoracic surgery equipment, a reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.

The lung cancer surgery equipment market is anticipated to show robust expansion in the coming years, reaching **$5.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%.** This growth during the forecast period can be attributed to the advancement of robotic-assisted and minimally invasive surgical tools, the integration of AI-enabled imaging and monitoring systems, increasing investment in research and academic institutions, the rising adoption of enhanced recovery after surgery (ERAS) protocols, and the expansion of specialized lung cancer treatment centers. Major trends expected in this period include the growing preference for minimally invasive lung surgeries, a rising demand for advanced imaging and diagnostic equipment, the integration of patient monitoring systems with surgical devices, an increasing focus on postoperative rehabilitation and aftercare, and the broader application of robotic-assisted thoracic surgery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Major Drivers Are Influencing Demand In The Lung Cancer Surgery Equipment Market?

The rising incidence of lung cancer is projected to fuel the expansion of the lung cancer surgery equipment market going forward. Lung cancer is a medical condition marked by the uncontrolled multiplication of abnormal cells within the lungs, frequently caused by smoking or adverse environmental exposure. The increase in lung cancer cases is largely attributed to heightened exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, coupled with an aging population. Lung cancer surgery equipment plays a crucial role in diagnosing the condition, removing cancerous tissue, and facilitating post-operative care through precise surgical interventions and continuous patient monitoring. For instance, in February 2025, according to the Cancer Council, an Australia-based non-profit organization, in 2024, an estimated 15,122 individuals were diagnosed with lung cancer in Australia, with the average age at diagnosis being 72. Lung cancer ranks as the fifth most commonly diagnosed cancer in the country, and approximately one in 20 Australians is expected to be diagnosed with it by the age of 85. Consequently, the increasing prevalence of lung cancer is driving the growth of the lung cancer surgery equipment market.

Which Segments Are Included In The Analysis Of The Lung Cancer Surgery Equipment Market?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

Which Trends Are Impacting The Growth Of The Lung Cancer Surgery Equipment Market?

Companies prominent in the **lung cancer surgery equipment market** are concentrating on creating devices for robotically assisted bronchoscopy. This focus aims to boost the accuracy and safety of tumor localization and biopsy, facilitate access to lung nodules that are difficult to reach, and support prompt and precise lung cancer diagnosis. Robotically assisted bronchoscopy is a sophisticated medical process employing robotic technology to guide a bronchoscope – a slender, adaptable tube – into the lungs with enhanced exactitude and command compared to conventional manual methods. An illustration of this trend is **Johnson and Johnson**, a US-based pharmaceutical company, which declared in **March 2025** that its **MONARCH QUEST system**, a cutting-edge robotic-assisted bronchoscopy technology, secured **U.S. FDA 510(k) clearance**. This particular system signifies the newest progression of the **MONARCH Platform**, specifically engineered to refine lung cancer diagnosis through procedures that are minimally invasive. The system is designed to connect with the **GE HealthCare OEC 3D mobile CBCT Imaging System**, enabling real-time, during-procedure 3D imaging. Such integration elevates the precision when targeting lung nodules, particularly those situated in challenging-to-access lung regions.

Which Key Industry Participants Are Active In The Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Read the full lung cancer surgery equipment market report here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lung Cancer Surgery Equipment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the Lung Cancer Surgery Equipment Market valued at in 2026, and what valuation is forecast for 2030?

The lung cancer surgery equipment market has experienced strong growth in recent years. It is projected to increase from $3.73 billion in 2025 to $3.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. The growth observed in the historic period can be attributed to factors such as the limited availability of advanced thoracic surgery equipment, a reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospitals and surgical clinics, and the adoption of standard biopsy and imaging procedures.

The lung cancer surgery equipment market is anticipated to experience robust expansion over the coming years. This market is projected to reach $5.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Key factors driving this growth during the forecast period include advancements in robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-enabled imaging and monitoring solutions, increased funding in research and academic institutions, a greater embrace of enhanced recovery after surgery (ERAS) protocols, and the proliferation of specialized centers for lung cancer treatment. Significant trends anticipated in this period encompass a rise in minimally invasive lung surgical procedures, a heightened need for sophisticated imaging and diagnostic gear, the merging of patient monitoring systems with surgical apparatus, an increased emphasis on rehabilitation and aftercare post-surgery, and the broadened use of robotic-assisted thoracic surgery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Drivers Are Influencing The Growth Of The Lung Cancer Surgery Equipment Market?

The increasing incidence of lung cancer is projected to drive the expansion of the lung cancer surgery equipment market moving forward. This condition involves the unchecked proliferation of abnormal cells within the lungs, frequently attributed to factors like smoking or detrimental environmental exposure. The rise in lung cancer diagnoses is largely due to increased exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, alongside a demographic shift towards an aging population. Lung cancer surgery equipment plays a crucial role in diagnosis, the excision of cancerous tissue, and aiding post-operative recovery through precise surgical procedures and patient surveillance. For example, in February 2025, data from the Cancer Council, an Australia-based non-profit organization, indicated that in 2024, approximately 15,122 individuals in Australia were diagnosed with lung cancer, with the mean age at diagnosis reported as 72. In Australia, lung cancer is the fifth most commonly diagnosed cancer, and it is anticipated that around one in 20 Australians will receive this diagnosis by the age of 85. Consequently, the rising prevalence of lung cancer is fueling the growth of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Organized Into Various Segments?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

How Are New Market Trends Shaping The Landscape Of The Lung Cancer Surgery Equipment Market?

Major entities operating in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy. This focus aims to boost the precision and safety of tumor localization and biopsy, improve access to difficult-to-reach lung nodules, and support the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, revealed that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system marks the latest evolution of the MONARCH Platform, which is designed to enhance the diagnosis of lung cancer through minimally invasive procedures. The system also interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, providing real-time, intraprocedural 3D imaging. This integration significantly improves the precision in targeting lung nodules, especially those found in hard-to-reach areas of the lung.

Who Are The Primary Competitors In The Global Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Regions Are Poised For Strategic Growth In The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lung Cancer Surgery Equipment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Lung Cancer Surgery Equipment Market Expected To Become By 2029 Compared With Its 2025 Level?

The lung cancer surgery equipment market size has demonstrated robust expansion in recent years. It is forecast to grow from $3.49 billion in 2024 to $3.73 billion in 2025, at a compound annual growth rate (CAGR) of 6.7%. The surge in the historic period can be attributed to the rising prevalence of smoking, increasing early diagnosis rates, improved surgical survival outcomes, higher adoption of lobectomy procedures, government cancer screening programs, growing hospital infrastructure, availability of skilled thoracic surgeons, a rise in open thoracotomy surgeries, limited alternatives to surgery, and reimbursement support for cancer surgeries.

The lung cancer surgery equipment market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $4.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by several factors, including an increased occurrence of lung cancer among non-smokers, the expanding global elderly demographic, the broadening scope of minimally invasive surgical techniques, a heightened need for robotic-assisted thoracic procedures, greater expenditure on healthcare, better outcomes in post-surgical recovery, an increase in outpatient thoracic interventions, supportive regulatory endorsements, heightened public understanding via lung cancer campaigns, and expanding insurance penetration in developing economies. Key trends anticipated during this period encompass the implementation of robotic-assisted surgical platforms, the application of AI in surgical preparation, the incorporation of 3D imaging into operations, the creation of more compact thoracoscopic instruments, upgraded visualization technologies, the proliferation of remote surgical methods, live intraoperative guidance, the deployment of intelligent staplers and devices, custom surgical tools produced through 3D printing, and AI-powered post-operative monitoring solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Are The Main Drivers Boosting The Lung Cancer Surgery Equipment Industry’s Expansion?

The increasing occurrence of lung cancer is anticipated to boost the expansion of the lung cancer surgery equipment market moving forward. Lung cancer is defined by the unrestrained proliferation of atypical cells within the lungs, frequently attributed to smoking or exposure to detrimental environmental factors. The surge in lung cancer incidents is primarily linked to heightened exposure to risk elements such as tobacco smoke, airborne pollutants, and workplace carcinogens, coupled with a demographic shift towards an older population. Lung cancer surgery equipment plays a crucial role in diagnosing the condition, excising malignant tissue, and facilitating post-operative recovery via accurate surgical procedures and continuous patient observation. As an illustration, the Cancer Council, an Australia-based non-profit organization, reported in February 2025 that an estimated 15,122 individuals in Australia were diagnosed with lung cancer in 2024, with the mean age at diagnosis being 72. In Australia, lung cancer stands as the fifth most prevalent cancer diagnosis, and it is projected that roughly one in 20 Australians will receive this diagnosis by the time they reach 85 years old. Consequently, the expanding incidence of lung cancer is propelling the advancement of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Segmented?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

How Are Emerging Market Trends Shaping The Lung Cancer Surgery Equipment Industry Landscape?

Major companies in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy to enhance the precision and safety of tumor localization and biopsy, improve access to hard-to-reach lung nodules, and support early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For example, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system represents the latest evolution of the MONARCH Platform, designed to improve the diagnosis of lung cancer through minimally invasive procedures. The system interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, allowing for real-time, intraprocedural 3D imaging. This integration improves the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.

Which Major Industry Participants Are Leading The Lung Cancer Surgery Equipment Market Growth?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Inc., Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Integra LifeSciences Corporation, Elekta AB, Accuray Incorporated, Richard Wolf GmbH, Angiodynamics Inc., B. Braun Melsungen AG, Quantum Surgical SAS, Sontec Instruments Inc., Novadaq Technologies Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Regional Markets Are Contributing Most To The Lung Cancer Surgery Equipment Industry Expansion?

North America was the largest region in the lung cancer surgery equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2025, By The Business Research Company

Lung Cancer Diagnostic And Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Lung Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Lung Cancer Surgery Equipment Industry?

The market size for lung cancer surgery equipment has been expanding methodically in the past few years. The market is projected to increase from $3.49 billion in 2024 to $3.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. The historical growth has been linked to factors such as the escalating prevalence of smoking, improving rates of early diagnosis, enhanced survival outcomes post-surgery, rising numbers of lobectomy procedures, government-initiated cancer screening programs, expanding hospital infrastructure, the presence of proficient thoracic surgeons, an increase in open thoracotomy surgeries, the scarcity of surgery substitutes, and financial assistance for cancer surgeries.

Significant expansion is expected for the lung cancer surgery equipment market in the forthcoming years, with projections estimating its value at $4.79 billion in 2029 and a compound annual growth rate (CAGR) of 6.5%. Factors predicted to drive market growth include growing incidence of lung cancer in non-smokers, an aging worldwide population, the rise of minimally invasive surgical methods, increasing demand for robotic-assisted thoracic surgery, expansion of healthcare spending, enhancement of post-surgery recovery times, increased thoracic procedures performed on an outpatient basis, favorable regulatory conditions, wider awareness due to lung cancer initiatives, and expanding insurance coverage in emerging markets. Key anticipated trends encompass the adoption of robotic-assisted surgical systems, the employment of artificial intelligence in surgical planning, the incorporation of 3D imaging in surgeries, the creation of smaller thoracoscopic devices, better visualization systems, the evolution of remote surgical methods, real-time intra-surgical navigation, the utilization of intelligent staplers and implements, the customization of surgical tools through 3D printing, and the application of AI in post-operative monitoring systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

What Forces Are Driving The Growth Of The Lung Cancer Surgery Equipment Industry?

The escalating incidence of lung cancer is projected to fuel the expansion of the lung cancer surgery equipment market. Lung cancer, typically caused by smoking or detrimental environmental exposure, occurs when abnormal cells proliferate uncontrollably in the lungs. The number of lung cancer cases is primarily increasing due to heightened exposure to risk factors such as tobacco smoke, air pollution, and workplace carcinogens, along with an aging population. Lung cancer surgical equipment is employed for diagnosing, extracting cancerous tissue, and facilitating post-surgery care via precise surgery and patient supervision. For instance, as per Cancer Council, a non-profit organization located in Australia, it was reported in February 2025 that there were approximately 15,122 lung cancer diagnoses in 2024, the average age of diagnosis being 72. In terms of frequency, lung cancer is the fifth most common cancer diagnosed in Australia, with about one in every 20 Australians anticipated to receive a diagnosis before the age of 85. Consequently, the escalating incidence of lung cancer is propelling the expansion of the lung cancer surgery equipment market.

What Is The Overview Of Market Segmentation In The Lung Cancer Surgery Equipment Industry?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

What Future Market Trends Are Projected For The Lung Cancer Surgery Equipment Industry?

Leading firms in the lung cancer surgery equipment industry are concentrating on the creation of robotic bronchoscopy devices to augment the accuracy and safety of tumor identification and biopsy, gain access to elusive lung nodules, and facilitate early and precise lung cancer diagnosis. Robotic bronchoscopy is a sophisticated medical practice that leverages robotic technology for directing a bronchoscope, a slim, bendable tube, into the lungs with increased accuracy and control compared to conventional manual methods. For instance, in March 2025, Johnson and Johnson, an American pharmaceutical business, revealed its MONARCH QUEST system, a groundbreaking robotic bronchoscopy innovation, which obtained U.S. FDA 510(k) clearance. This system, the latest iteration of the MONARCH Platform, aims to enhance lung cancer diagnosis through less invasive operations. It collaborates with the GE HealthCare OEC 3D mobile CBCT Imaging System, which enables real-time, intraprocedural 3D imaging possible. This collaboration helps in the precise targeting of lung nodules, particularly the ones present at inaccessible lung areas.

Who Are The Primary Players Operating Across The Global Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Inc., Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Integra LifeSciences Corporation, Elekta AB, Accuray Incorporated, Richard Wolf GmbH, Angiodynamics Inc., B. Braun Melsungen AG, Quantum Surgical SAS, Sontec Instruments Inc., Novadaq Technologies Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Offers The Most Growth Potential For The Lung Cancer Surgery Equipment Market Through 2029?

North America was the largest region in the lung cancer surgery equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model